Thursday, October 7, 2021

The Company Turning The $812B Tobacco Space on its Head

Unsubscribe


As the world transitions to a tobacco less world, this company may lead the way with a game changing product!

The Small-cap company has created a nicotine and tobacco free smoking experience to take on Big Tobacco with ex-big tobacco executives leading the way! 

The company's patent-pending Beyond Tobacco™ products have been expertly engineered to replicate all aspects of the tobacco smoking experience . 

Launched first in the United States in Ohio in Q4 2020, legal-aged smokers became able to get the company's product in Original, Smooth, and Menthol varieties.

It has since expanded to Illinois, Georgia, Alabama, California, Florida, Michigan, and Mississippi! The company also has global expansion efforts in Canada, the U.K and Australia! 

The company is commercializing aggressively between its existing sales channels (both wholesale and B2C to smokers aged 21 ) as well as contacts made at events such as trade shows to build distribution. As of early August 2021, it is sold in approximately 500 stores in the United States, representing significant short-term growth in contrast to approximately 300 stores as of mid-July 2021. 

With revenues climbing and representation from Crossmark Inc., a major driving force for JUUL, helping to lead the company to a buyout from Altria for a staggering $38B, it is the time to be watching sharply!


DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that StockEarnings Inc. "StockEarnings's" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. StockEarnings's has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment.

Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at http: //www.sec .gov and the Financial Industry Regulatory Authority (the "FINRA") at http: //www. FINRA .org. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at http: //www.sec .gov/consumer as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence.

You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company.

Unsubscribe

StockEarnings
110, Wall Street, Floor 3, New York, NY 10005
W: 877.6.STOCKS

StockEarnings.com

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...